Researchers in the United States have developed an inhalable, self-administered COVID-19 vaccine that is shelf-stable at room temperature for up to a duration of three months. The researchers discovered that this delivery mechanism, an exosome produced from the lung and termed LSC-Exo, is more effective for avoiding the lung’s lining than the lipid-based nanoparticles currently […]
Researchers in the United States have developed an inhalable, self-administered COVID-19 vaccine that is shelf-stable at room temperature for up to a duration of three months. The researchers discovered that this delivery mechanism, an exosome produced from the lung and termed LSC-Exo, is more effective for avoiding the lung’s lining than the lipid-based nanoparticles currently […]
\
\
